Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk.
Whereas this review is based on the available evidence, interpretation of the data is entirely hypothetical and subjective. To a large degree the review reflects our long-standing fascination with the role of the sympathetic overactivity in hypertension. The basic tenet is that sympathetic overactivity in hypertension may lead to a number of secondary changes, all of which are conductive to coronary heart disease. We also propose that insulin resistance and hypertension are associated through an underlying hemodynamic abnormality and again find good evidence for a possible role of sympathetics in the genesis of such hemodynamic changes. Future research in our laboratory will be oriented toward experimental testing of various aspects of the proposed sympathetic overactivity/hypertension/insulin resistance hypothesis.
Julius
S
S
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.
Gudbrandsson
T
T
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D006332:Cardiomegaly; D003327:Coronary Disease / Q000209:etiology*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D009132:Muscles / Q000098:blood supply; D012307:Risk Factors; D013564:Sympathetic Nervous System / Q000502:physiology*
D000959:Antihypertensive Agents; D008055:Lipids